G-15 (drug)
G-15 (drug)[edit]
G-15 is a synthetic compound that acts as a selective antagonist of the G protein-coupled estrogen receptor (GPER), also known as GPR30. It is primarily used in research settings to study the physiological and pathological roles of GPER in various tissues.
Chemical Structure and Properties[edit]
G-15 is a non-steroidal compound with a complex chemical structure that allows it to selectively bind to GPER without significant interaction with classical estrogen receptors, such as ERα and ERβ. This selectivity is crucial for its use in research, as it enables scientists to isolate the effects mediated by GPER.
Mechanism of Action[edit]
G-15 functions by competitively inhibiting the binding of endogenous estrogens to GPER. By blocking this receptor, G-15 can modulate various signaling pathways that are activated by GPER, including those involved in cell proliferation, apoptosis, and migration. This makes it a valuable tool for studying estrogen-related signaling in non-genomic pathways.
Research Applications[edit]
G-15 is widely used in preclinical studies to explore the role of GPER in different physiological processes and diseases. Some of the key areas of research include:
- Cardiovascular System: Investigating the protective effects of GPER activation in cardiovascular diseases.
- Cancer: Understanding the role of GPER in the progression of hormone-dependent cancers, such as breast and ovarian cancer.
- Metabolic Disorders: Studying the impact of GPER on glucose metabolism and obesity.
Pharmacokinetics[edit]
The pharmacokinetic profile of G-15 is not extensively documented, as it is primarily used in vitro and in animal models. However, its solubility, stability, and bioavailability are important considerations for experimental design.
Safety and Toxicity[edit]
As G-15 is mainly used in laboratory research, comprehensive safety and toxicity data in humans are not available. Researchers handling G-15 should follow standard laboratory safety protocols to minimize exposure and potential risks.
Also see[edit]
- G protein-coupled estrogen receptor
- Estrogen receptor
- Selective estrogen receptor modulator
- Non-genomic actions of estrogen
| Pharmacomodulation | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian